Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Insilico's Chemistry42 AI system integrated into UCB's drug discovery programs 2021-03-09 22:00
Bimekizumab Demonstrated Long-Term Maintenance of Complete or Almost Complete Skin Disease Resolution for Psoriasis Patients in BE ABLE 2 Extension Study 2019-03-04 09:45
New Data Affirms Strength of UCB Immuno-Dermatology Portfolio 2019-03-01 20:56
1